BioCentury
ARTICLE | Product Development

FDA expanding U.S. COVID-19 test capacity, industry ramping up to meet demand

BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.

March 17, 2020 9:54 PM UTC
Updated on Mar 25, 2020 at 7:36 PM UTC

The U.S. FDA Monday night announced new policies and Emergency Use Authorizations to expand COVID-19 test capacity.

Diagnostics companies are also stepping up to meet demand. Qiagen is increasing production of RNA extraction kits, and more companies are seeking and obtaining authorization to offer tests. ...